Cargando…

‘Psoriasis 1’ reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF-κB and STAT signaling pathways

‘Psoriasis 1’, a Chinese herbal medicine (CHM) formulation, is extensively used to treat psoriasis in China. Although this CHM formulation yields good therapeutic effect, the underlying mechanism of how this works remains unknown. The present study aimed to test the hypothesis that the CHM formulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wen, Gao, Yang, Yu, Xianhua, Yuan, Yuan, Yi, Jun, Zhang, Zhen, Cheng, Yuxing, Li, Yong, Peng, Xing, Cha, Xushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102645/ https://www.ncbi.nlm.nih.gov/pubmed/30015892 http://dx.doi.org/10.3892/mmr.2018.9262

Ejemplares similares

'Psoriasis 1' reduces T-lymphocyte-mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor-mediated STAT4 inactivation
por: Gao, Yang, et al.
Publicado: (2020)

Psoriasis-Like Inflammation Induced Renal Dysfunction through the TLR/NF-κB Signal Pathway
por: Ren, Fang, et al.
Publicado: (2020)

Alpha-7 nicotinic acetylcholine receptor agonist alleviates psoriasis-like inflammation through inhibition of the STAT3 and NF-κB signaling pathway
por: Chen, Yiwen, et al.
Publicado: (2022)

Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis
por: Karrys, Amitis, et al.
Publicado: (2018)

PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines
por: Dou, Rongkun, et al.
Publicado: (2017)

Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
por: Kjær, Thomas Nordstrøm, et al.
Publicado: (2015)

Circadian Gene Clock Regulates Psoriasis-Like Skin Inflammation in Mice
por: Ando, Noriko, et al.
Publicado: (2015)

Correction: PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines
por: Dou, Rongkun, et al.
Publicado: (2018)

Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis
por: Tao, Tingjun, et al.
Publicado: (2022)

The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like Skin Inflammation
por: Martínez-Torres, Isaí, et al.
Publicado: (2022)

Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice
por: Shinno-Hashimoto, Hiroyo, et al.
Publicado: (2022)

P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
por: Chen, Haiming, et al.
Publicado: (2022)

Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice
por: Jeon, Yoon-Jae, et al.
Publicado: (2017)

Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation
por: Ma, Lei, et al.
Publicado: (2018)

Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response
por: Zákostelská, Zuzana, et al.
Publicado: (2016)

Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back
por: Madsen, Marie, et al.
Publicado: (2018)

Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice
por: Nakao, Momoko, et al.
Publicado: (2020)

Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice
por: Wang, Aixue, et al.
Publicado: (2023)

The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis
por: Okada, Karin, et al.
Publicado: (2020)

STAT3 Activation in Psoriasis and Cancers
por: Kishimoto, Megumi, et al.
Publicado: (2021)

Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
por: Thatikonda, Sowjanya, et al.
Publicado: (2020)

Cinnamaldehyde inhibits psoriasis-like inflammation by suppressing proliferation and inflammatory response of keratinocytes via inhibition of NF-κB and JNK signaling pathways
por: Ding, Zhenzhen, et al.
Publicado: (2021)

Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation
por: Xu, Fengli, et al.
Publicado: (2019)

TaaI/Cdx-2 AA Variant of VDR Defines the Response to Phototherapy amongst Patients with Psoriasis
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Aryl Hydrocarbon Receptor Repressor Is Hypomethylated in Psoriasis and Promotes Psoriasis-like Inflammation in HaCaT Cells
por: Um, Ji-Young, et al.
Publicado: (2021)

Therapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Kim, Kyung Eun, et al.
Publicado: (2016)

Gomisin M2 alleviates psoriasis-like skin inflammation by inhibiting inflammatory signaling pathways
por: Kim, Namkyung, et al.
Publicado: (2021)

Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway
por: Liu, Aimin, et al.
Publicado: (2020)

miR-489-3p inhibits TLR4/NF-κB signaling to prevent inflammation in psoriasis
por: Ye, Yujian, et al.
Publicado: (2021)

MiR-125a-3p alleviates hyperproliferation of keratinocytes and psoriasis-like inflammation by targeting TLR4/NF-κB pathway
por: Jin, Zhao, et al.
Publicado: (2023)

Emerging role of IκBζ in inflammation: Emphasis on psoriasis
por: Gautam, Preeti, et al.
Publicado: (2022)

Skin Barrier Dysregulation in Psoriasis
por: Orsmond, Andreas, et al.
Publicado: (2021)

Psoriasis: A STAT3-Centric View
por: Calautti, Enzo, et al.
Publicado: (2018)

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways
por: Nair, Rajan P., et al.
Publicado: (2009)

CD8(+) T cells Mediate RAS-induced Psoriasis-like Skin Inflammation Through IFN-γ
por: Gunderson, Andrew J., et al.
Publicado: (2012)

Unprocessed interleukin-36α regulates psoriasis-like skin inflammation in co-operation with interleukin-1
por: Milora, Katelynn A., et al.
Publicado: (2015)

Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation
por: Wang, Yibing, et al.
Publicado: (2019)

Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Fujii, Kento, et al.
Publicado: (2020)

Estrogen Acts Through Estrogen Receptor-β to Promote Mannan-Induced Psoriasis-Like Skin Inflammation
por: Wu, Huimei, et al.
Publicado: (2022)

The profile of Cyr61 expression data correlate to the skin inflammation in psoriasis
por: Wu, Pinru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nmeumb8g0r5u3gpnamtg56ne3k